Shankar Gopi 4
4 · Larimar Therapeutics, Inc. · Filed Feb 9, 2023
Insider Transaction Report
Form 4
Shankar Gopi
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-07+180,000→ 180,000 totalExercise: $5.88Exp: 2033-02-07→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on February 7, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.